Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Sales | 1,128,700 | 1,174,100 | 1,094,000 | 1,086,900 | 993,000 |
| Cost of Goods | 265,100 | 286,200 | 292,400 | 304,000 | 231,800 |
| Gross Profit | 863,600 | 887,900 | 801,600 | 782,900 | 761,200 |
| Operating Expenses | 505,600 | 577,300 | 507,700 | 515,400 | 487,800 |
| Operating Income | 358,100 | 310,800 | 294,300 | 267,500 | 274,200 |
| Other Income | 6,400 | 4,700 | 7,400 | 3,800 | 3,800 |
| Pre-tax Income | 364,500 | 315,500 | 301,700 | 271,300 | 278,000 |
| Income Tax | 53,900 | 35,300 | 27,000 | 29,000 | 28,300 |
| Net Income Continuous | 310,600 | 280,200 | 274,700 | 242,300 | 249,700 |
| Net Income | $310,600 | $280,200 | $274,700 | $242,300 | $249,700 |
| EPS Basic Total Ops | 0.50 | 0.45 | 0.44 | 0.39 | 0.40 |
| EPS Basic Continuous Ops | 0.50 | 0.45 | 0.44 | 0.39 | 0.40 |
| EPS Diluted Total Ops | 0.49 | 0.44 | 0.43 | 0.38 | 0.39 |
| EPS Diluted Continuous Ops | 0.49 | 0.44 | 0.43 | 0.38 | 0.39 |
| EBITDA(a) | $382,600 | $334,700 | $317,400 | $289,200 | $294,800 |